Original BioMedicals Co., Ltd. (6483.TWO)
- Previous Close
12.00 - Open
12.05 - Bid 11.60 x --
- Ask 12.00 x --
- Day's Range
11.65 - 12.05 - 52 Week Range
9.93 - 21.00 - Volume
28,885 - Avg. Volume
228,901 - Market Cap (intraday)
795.204M - Beta (5Y Monthly) 0.08
- PE Ratio (TTM)
-- - EPS (TTM)
-1.14 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Original BioMedicals Co., Ltd., a biotechnology company, chemical entities to solve unmet medical needs in Taiwan. It develops (A01) Radprotect, a pre-clinical product to protects against radiation exposer; (A02) CCM-Ami, which protects normal tissues from the toxic effects of chemotherapeutic agents and ionizing radiation; and ((P01)GLP-1 CCM for the treatment of type 2 diabetes. The company was founded in 2011 and is based in Taipei, Taiwan.
www.i-obm.com/English_Version/index.aspx23
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 6483.TWO
View MorePerformance Overview: 6483.TWO
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6483.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6483.TWO
View MoreValuation Measures
Market Cap
791.90M
Enterprise Value
562.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.10
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-15.06%
Return on Equity (ttm)
-25.78%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-75M
Diluted EPS (ttm)
-1.14
Balance Sheet and Cash Flow
Total Cash (mrq)
241.19M
Total Debt/Equity (mrq)
4.70%
Levered Free Cash Flow (ttm)
-60.06M